Novel pathways for negative regulation of inflammatory cytokines centered on receptor expression.
Mantovani
A
A
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Garlanda
C
C
D000818:Animals; D016207:Cytokines / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D054390:Receptors, CCR2; D019707:Receptors, Chemokine / Q000235:genetics / Q000378:metabolism; D018121:Receptors, Cytokine / Q000235:genetics* / Q000378:metabolism; D017472:Receptors, Interleukin-1 / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction
C515334:CCR2 protein, human; D016207:Cytokines; D018836:Inflammation Mediators; D054390:Receptors, CCR2; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine; D017472:Receptors, Interleukin-1